Get the tools used by (smart)2 investors.

AstraZeneca PLCLSE:AZN

United Kingdom / Healthcare / Pharmaceuticals

Join now and get access to the full platform

Exchange Data

Hide this widget
11,808.00 GBX
Price
24.00 (0.20%)
Day change
9,670.00 - 13,388.00
52-week range

Summary of AstraZeneca PLC

Hide this widget

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The...

Dec 31, 2024
Latest Report
Apr 29, 2025
Next Earnings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data could not be retrieved

Data Explorer

Hide this widget

Peer Benchmarks

Finbox Fair Value

Financial Health

Health Details
Hide this widget
GREAT
Financial Health for AstraZeneca is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.

Financial Models for AstraZeneca PLC

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue36,68835,93643,1909,43211,894
Operating Income7,2897,56810,3272,6212,702
Net Profit2,7204,6715,6197531,198
Diluted EPS1.752.993.590.480.77
EBITDA11,36911,15814,0313,3203,351
Balance Sheet
Cash & ST Invest.5,1654,5974,4134,5974,413
Current Assets18,68919,65320,62919,65320,629
Total Assets79,81379,32183,09779,32183,097
Current Liabilities21,75023,95822,25823,95822,258
Total Liabilities49,15848,59850,45248,59850,452
Total Equity30,65530,72332,64530,72332,645
Total Debt25,75523,25824,33023,25824,330
Cash Flow Statement
Cash Flow Operations8,1138,1159,4741,8672,322
Cash From Investing(2,449)(3,188)(6,374)(845)(943)
Cash From Financing(5,644)(5,151)(3,192)(228)(536)
Free Cash Flow7,2117,0477,9371,4551,756

Analyst Notes

March 21, 2025
Hide this widget
    All rights reserved. Terms Of Use